.jpg?format=webp&width=780)
ST2 functions as a receptor for the cytokine IL-33. It has been implicated in carcinogenesis. This study sought to mechanistically determine how ST2 and IL-33 function to support cancer stem cell (CSC) activity and drive gastric cancer (GC) pathogenesis. ST2+ subpopulation spontaneously arose during gastric tumorigenesis. A thorough evaluation of ST2 and IL-33 expression in gastric tumors revealed an overlapping expression pattern, notably in poorly differentiated GC and metastasis foci. These findings establish ST2 as a functional CSC marker that fortifies the Wnt signal while availing a novel therapeutic strategy to suppress GC progression by targeting the IL-33/ST2/Bcl-xL signalling axis.
Like
Save
Share